drugset / Trial / NCT05939219
Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of this clinical trial is to evaluate the consistency of the 15-valent pneumococcal conjugate vaccine in three batches of the 3-month-old population, as well as the immunogenicity and safety of vaccination in the 7-5-year-old population
Timeline
- Start
- 2023-07-01
- Primary completion
- 2025-01-31
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 15-Valent Pneumococcal Conjugate Vaccine | Vaccine | — | — |
| Comparator | Prevnar 13 | Vaccine | — | — |
Indications
No indication recorded.